HIMS Hims & Hers Health Inc
13,361
$18.65
$1.77
(10.49%)
| Watchers | 13,361 |
| 52-Wk Low | $5.65 |
| 52-Wk High | $20.11 |
| Market Cap | $3.63B |
| Volume | 16.24M |
| 52-Wk High | $20.11 |
| 52-Wk Low | $5.65 |
Unpacking the Latest Options Trading Trends in Hims & Hers HealthBenzinga • 5 days ago
read more...
Share to Feed
Health platform Hims & Hers Health Inc. announced Monday that it's rolling out injectable weight-loss drugs that cost a fraction of the price of competitors Wegovy and Ozempic.Hims & Hers says its...
:max_bytes(150000):strip_icc()/INV_Hims_Logo_GettyImages-2153332008-c60ca06fff1b401583d188c525461437.jpg){kind=logo}
Injections will have the same key ingredient as popular weight-loss drugs Ozempic and Mounjaro
Rafael Henrique / SOPA Images / LightRocket via Getty Images
Key TakeawaysShares of telehealth...
:max_bytes(150000):strip_icc()/GettyImages-2151506889-ae40752d21524ae1babe128f355e1d75.jpg)
Scott McIntyre / Bloomberg via Getty Images
Key TakeawaysTech sector gains helped power the Nasdaq to a record intraday high on Monday, May 20, 2024, while the S&P 500 was also higher. Cruise...
Hims & Hers Health is introducing access to compounded GLP-1 weight loss injections as Ozempic and Wegovy soar in popularity...
Top Midday Stories: Hims & Hers Health Rises on Weight Loss Injections; Apple's China Discount; Jabil Names CEO After Probe; Norwegian Boosts Guidance; Google's Finland Investment...
Hims & Hers Health expands its weight loss offerings with GLP-1 injections and oral medication kits. Pricing starts at $79/month.
read more...
Hims & Hers Health to Offer Injectable Weight-Loss Drugs on Telehealth Platform...
read more...
The GLP-1 market has faced supply constraints in recent months as the drugs like Ozempic and Wegovy skyrocket in popularity...